N. V. Kholodnova
N. V. Kholodnova has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Anastasiya I. Makulova
Pirogov Russian National Research Medical University
4 shared publications - A.O. Тoporkova3 shared publications
- H. A. Sarkisyan
Pirogov Russian National Research Medical University
3 shared publications - Irina E. Turina
I.M. Sechenov First Moscow State Medical University of the Russian Federation (Sechenov University)
3 shared publications - L. M. Makarova
Speransky Children’s City Clinical Hospital № 9
3 shared publications - Lyudmila N. Mazankova
Russian Medical Academy of Continuous Professional Education
3 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (1)
A newborn with severe asphyxia and rhabdomyolysis. Experience of treatment using various methods of renal replacement therapy and hemosorption
Новорожденный с тяжелой асфиксией и рабдомиолизом. Опыт лечения с применением различных методов заместительной почечной терапии и гемосорбции
- 1 January 2025
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 13 (1)
Open AccessA newborn with severe asphyxia and rhabdomyolysis. Experience of treatment using various methods of renal replacement therapy and hemosorption
Новорожденный с тяжелой асфиксией и рабдомиолизом. Опыт лечения с применением различных методов заместительной почечной терапии и гемосорбции
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (2)
Clinical observation of a newborn with mitochondrial hepatopathy due to a mutation in the MPV17 gene
Mitochondrial deoxyribonucleic acid depletion syndrome is a group of diseases with autosomal recessive inheritance associated with mutations in nuclear genes that encode components of the respiratory chain of "cellular energy stations". The disease is characterized by a decrease in the number of copies of the genetic material of mitochondria and, as a consequence, irreversible loss of their oxidative capacity with the accumulation of damaging metabolites. Currently, the pathology tends to spread and occurs with a frequency of 4.7 to 12.5 per 100,000 population, especially in some regions (in our case, a patient from the North Caucasus region is described). Heterogeneity of clinical manifestations is due to the variability of gene defects: myopathic, encephalomyopathic, and hepatocerebral forms of the disease are distinguished. Diseases associated with depletion of mitochondrial deoxyribonulinic acid manifest in the early neonatal period with critical metabolic disorders (hypoglycemia, lactatacidosis), clinically manifested by neurological deficit, liver failure and often lead to death. The development of liver cirrhosis in such patients requires liver transplantation, the efficacy of which is less than 50%. This article describes a clinical case of severe depletion syndrome associated with a homozygous mutation in the acceptor splice site, intron 7 of the MPV17 gene (OMIM #251880), (chr2:27532851T>C) resulting in a nucleotide substitution (NM_002437.5: c.462-2A>G), not previously described in the Russian-language literature. In contrast to most of the described observations, the first clinical manifestations in the presented patient were erased and included signs of lethargic baby syndrome. Despite symptomatic therapy, the patient required liver transplantation at the age of 4 months due to the development of cirrhosis. The article highlights the issues of clinic, diagnosis, and treatment of mitochondrial deoxyribonucleic acid depletion syndrome on the example of the observed child and patients previously described both in Russian and foreign literature. Key words: mitochondrial DNA depletion syndrome, hepatocerebral form, neonatal cholestasis, liver, liver failure, neurologic disorders, liver transplantation
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (2)
Clinical observation of a newborn with mitochondrial hepatopathy due to a mutation in the MPV17 gene
Mitochondrial deoxyribonucleic acid depletion syndrome is a group of diseases with autosomal recessive inheritance associated with mutations in nuclear genes that encode components of the respiratory chain of "cellular energy stations". The disease is characterized by a decrease in the number of copies of the genetic material of mitochondria and, as a consequence, irreversible loss of their oxidative capacity with the accumulation of damaging metabolites. Currently, the pathology tends to spread and occurs with a frequency of 4.7 to 12.5 per 100,000 population, especially in some regions (in our case, a patient from the North Caucasus region is described). Heterogeneity of clinical manifestations is due to the variability of gene defects: myopathic, encephalomyopathic, and hepatocerebral forms of the disease are distinguished. Diseases associated with depletion of mitochondrial deoxyribonulinic acid manifest in the early neonatal period with critical metabolic disorders (hypoglycemia, lactatacidosis), clinically manifested by neurological deficit, liver failure and often lead to death. The development of liver cirrhosis in such patients requires liver transplantation, the efficacy of which is less than 50%. This article describes a clinical case of severe depletion syndrome associated with a homozygous mutation in the acceptor splice site, intron 7 of the MPV17 gene (OMIM #251880), (chr2:27532851T>C) resulting in a nucleotide substitution (NM_002437.5: c.462-2A>G), not previously described in the Russian-language literature. In contrast to most of the described observations, the first clinical manifestations in the presented patient were erased and included signs of lethargic baby syndrome. Despite symptomatic therapy, the patient required liver transplantation at the age of 4 months due to the development of cirrhosis. The article highlights the issues of clinic, diagnosis, and treatment of mitochondrial deoxyribonucleic acid depletion syndrome on the example of the observed child and patients previously described both in Russian and foreign literature. Key words: mitochondrial DNA depletion syndrome, hepatocerebral form, neonatal cholestasis, liver, liver failure, neurologic disorders, liver transplantation
- Open Access
- 29 December 2024
- Published by Russian Dialysis Society in Nephrology and Dialysis
- Vol. 26 (4) , 487-497
Spontaneous abdominal aortic thrombosis, a rare cause of acute kidney injury in a newborn
Introduction: Neonatal aortic thrombosis is a rare but serious condition with potentially severe outcomes. Approximately 80% of cases are linked to umbilical catheterization, while not non-catheter-related cases are classified as spontaneous. Clinical presentation varies with the location and severity of thrombosis, ranging from asymptomatic cases to life-threatening emergency such as cardiac or respiratory failure, necrotizing enterocolitis, limb gangrene, or acute kidney injury (AKI) renal artery involvement.Materials and methods: This report describes a case of spontaneous abdominal aortic thrombosis in a newborn girl, resulting in AKI necessitating renal replacement therapy.Results: A full-term newborn breastfed girl experiences clinical deterioration on day 11, presenting with lethargy, feeding refusal, macrohematuria, anuria on day 12. Ultrasound Doppler revealed bilateral renal artery thrombosis, with laboratory findings of hyperazotemia, hypernatremia, hemoconcentration, and 18% weight loss. Despite fluid replacement, electrolyte correction, anuria persisted, requiring peritoneal dialysis. CT angiography confirmed abdominal aortic thrombosis extending from the superior mesenteric artery to the common femoral arteries. Treatment included unfractionated heparin and tissue plasminogen activator (Alteplase), but kidney function did not recover, leaving the child dialysis-dependent.Conclusions: This case highlights the rare occurrence of abdominal aortic thrombosis in the neonatal period, leading to AKI and chronic kidney disease (CKD) 5D due to cortical necrosis. Neonates are particularly vulnerable to thrombotic complications due to factors such a dehydration, hypernatremia, and polycythemia.
- 29 December 2024
- Published by Russian Dialysis Society in Nephrology and Dialysis
- Vol. 26 (4) , 487-497
Open AccessSpontaneous abdominal aortic thrombosis, a rare cause of acute kidney injury in a newborn
Introduction: Neonatal aortic thrombosis is a rare but serious condition with potentially severe outcomes. Approximately 80% of cases are linked to umbilical catheterization, while not non-catheter-related cases are classified as spontaneous. Clinical presentation varies with the location and severity of thrombosis, ranging from asymptomatic cases to life-threatening emergency such as cardiac or respiratory failure, necrotizing enterocolitis, limb gangrene, or acute kidney injury (AKI) renal artery involvement.Materials and methods: This report describes a case of spontaneous abdominal aortic thrombosis in a newborn girl, resulting in AKI necessitating renal replacement therapy.Results: A full-term newborn breastfed girl experiences clinical deterioration on day 11, presenting with lethargy, feeding refusal, macrohematuria, anuria on day 12. Ultrasound Doppler revealed bilateral renal artery thrombosis, with laboratory findings of hyperazotemia, hypernatremia, hemoconcentration, and 18% weight loss. Despite fluid replacement, electrolyte correction, anuria persisted, requiring peritoneal dialysis. CT angiography confirmed abdominal aortic thrombosis extending from the superior mesenteric artery to the common femoral arteries. Treatment included unfractionated heparin and tissue plasminogen activator (Alteplase), but kidney function did not recover, leaving the child dialysis-dependent.Conclusions: This case highlights the rare occurrence of abdominal aortic thrombosis in the neonatal period, leading to AKI and chronic kidney disease (CKD) 5D due to cortical necrosis. Neonates are particularly vulnerable to thrombotic complications due to factors such a dehydration, hypernatremia, and polycythemia.
- Open Access
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 63-69
Hypogalactia as a cause of neonatal hypernatremia
Neonatal hypernatremia is a condition in which the concentration of sodium in the blood of a newborn child exceeds 145 mmol/l. The causes of this pathology may be kidney disease, endocrine problems, transdermal water loss, iatrogenic sodium overload. In addition, dehydration due to insufficient breastfeeding remains one of the important factors leading to hypernatremia. Clinical signs include: significant weight loss, decreased skin turgor, anxiety, fever, seizures, and direct hyperbilirubinemia. The main complications of this condition are intracranial hemorrhages, venous sinus thrombosis and acute renal tubule necrosis. Infusion therapy and adequate oral nutrition are used to correct hypernatremia. The article presents a clinical case of hypernatremia in a newborn child caused by hypogalactyly in the mother. The purpose of the demonstration is to raise awareness and alertness among pediatricians and neonatologists about the possibility of this problem.
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 63-69
Open AccessHypogalactia as a cause of neonatal hypernatremia
Neonatal hypernatremia is a condition in which the concentration of sodium in the blood of a newborn child exceeds 145 mmol/l. The causes of this pathology may be kidney disease, endocrine problems, transdermal water loss, iatrogenic sodium overload. In addition, dehydration due to insufficient breastfeeding remains one of the important factors leading to hypernatremia. Clinical signs include: significant weight loss, decreased skin turgor, anxiety, fever, seizures, and direct hyperbilirubinemia. The main complications of this condition are intracranial hemorrhages, venous sinus thrombosis and acute renal tubule necrosis. Infusion therapy and adequate oral nutrition are used to correct hypernatremia. The article presents a clinical case of hypernatremia in a newborn child caused by hypogalactyly in the mother. The purpose of the demonstration is to raise awareness and alertness among pediatricians and neonatologists about the possibility of this problem.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 12 (1)
Hemoperfusion in a newborn with early neonatal sepsis (clinical case)
Гемосорбция у новорожденного c ранним неонатальным сепсисом (клинический случай)
- 1 January 2024
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 12 (1)
Open AccessHemoperfusion in a newborn with early neonatal sepsis (clinical case)
Гемосорбция у новорожденного c ранним неонатальным сепсисом (клинический случай)
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Clinical experience of peritoneal dialysis in newborns and infants in maternity clinics and hospitals without special renal replacement therapy units
Опыт проведения перитонеального диализа у новорожденных и детей первых месяцев жизни в условиях родовспомогательных учреждений и стационаров, не
- 1 January 2023
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 11 (1)
Clinical experience of peritoneal dialysis in newborns and infants in maternity clinics and hospitals without special renal replacement therapy units
Опыт проведения перитонеального диализа у новорожденных и детей первых месяцев жизни в условиях родовспомогательных учреждений и стационаров, не
- Open Access
- 14 December 2020
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 19 (4) , 58-63
The modern view of congenital cytomegalovirus infection: clinical observations
Тhis work is a continuation of the literature review «The modern view of congenital cytomegalovirus infection» and is devoted to the clinical cases. Particular attention is paid to the severity of congenital cytomegalovirus infection (CCMVI), as well as the its clinical variability, including developmental anomalies. The variety of clinical forms requires a wide range of examinations to identify all this infection manifestations in a newborn child and children in the first months of life, as well as the doctors alertness regarding the timely diagnosis of intrauterine infections based on the existing clinical features. The presented cases demonstrate the CCMVI clinical manifestations: the «classical» generalized manifest form, with a specific clinical, laboratory and instrumental findings, the severe generalized CCMVI with kidney congenital malformation and postnatal development of congenital cataract.
- 14 December 2020
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 19 (4) , 58-63
Open AccessThe modern view of congenital cytomegalovirus infection: clinical observations
Тhis work is a continuation of the literature review «The modern view of congenital cytomegalovirus infection» and is devoted to the clinical cases. Particular attention is paid to the severity of congenital cytomegalovirus infection (CCMVI), as well as the its clinical variability, including developmental anomalies. The variety of clinical forms requires a wide range of examinations to identify all this infection manifestations in a newborn child and children in the first months of life, as well as the doctors alertness regarding the timely diagnosis of intrauterine infections based on the existing clinical features. The presented cases demonstrate the CCMVI clinical manifestations: the «classical» generalized manifest form, with a specific clinical, laboratory and instrumental findings, the severe generalized CCMVI with kidney congenital malformation and postnatal development of congenital cataract.
- Open Access
- 6 December 2019
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 18 (4) , 56-63
The modern view of congenital cytomegalovirus infection: diagnosis, treatment and prevention
A literature review of the works of foreign and domestic authors is devoted to modern approaches to the diagnosis, treatment and prevention of congenital cytomegalovirus infection (cCMV). The data of international consensuses are presented: «Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management» adopted by the cCMV group from the European society for pediatric infectious diseases (ESPID) in Leipzig, Germany in 2015, and «Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy» by an informal International Congenital Cytomegalovirus Recommendations Group (ICCRG), established in Brisbane, Australia in 2015 as part of the 5th International cCMV Conference about evidence-based treatment cCMV using antiviral drugs and immunotherapy. Particular attention is paid to the prevention of cCMV in both pregnant and newborns, as well as data from international studies on the cytomegalovirus vaccination.
- 6 December 2019
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 18 (4) , 56-63
Open AccessThe modern view of congenital cytomegalovirus infection: diagnosis, treatment and prevention
A literature review of the works of foreign and domestic authors is devoted to modern approaches to the diagnosis, treatment and prevention of congenital cytomegalovirus infection (cCMV). The data of international consensuses are presented: «Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management» adopted by the cCMV group from the European society for pediatric infectious diseases (ESPID) in Leipzig, Germany in 2015, and «Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy» by an informal International Congenital Cytomegalovirus Recommendations Group (ICCRG), established in Brisbane, Australia in 2015 as part of the 5th International cCMV Conference about evidence-based treatment cCMV using antiviral drugs and immunotherapy. Particular attention is paid to the prevention of cCMV in both pregnant and newborns, as well as data from international studies on the cytomegalovirus vaccination.
- Open Access
- 8 October 2019
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 18 (3) , 46-52
The modern view of congenital Сytomegalovirus infection
Congenital cytomegalovirus infection (CMVI) ranks first among congenital infections, making contribution significantly to the variety of congenital defects formation. The review describes in details the pathogenic mechanisms of the virus effects on the fetus and newborn. Congenital CMVI develops as a result of infection of the mother with the virus or its reactivation, causing an active infection. CMV is pantropic. Infected cells acquire the characteristic appearance of an «owl’s eye» due to a 3—4-fold increase in size, and the cytoplasm is visualized only in the form of a thin strip due to the large diameter of the nucleus. With a congenital CMV infection, the virus itself, its DNA or antigens is detected in biological media up to 14—21 days of life. The manifest and asymptomatic form of infection is distinguished.Attention is drawn to the various clinical findings and long-term outcomes of the infection. When the fetus is infected in the early stages of pregnancy, various malformations of the central nervous system, cardiovascular, kidneys, etc. are formed. When infected in the late stages of pregnancy, a variety of diseases and pathological conditions are revealed in newborns. In 40—90% of newborns with manifest CMVI, there are long-term neurological consequences and hearing loss, as well as damage to the organ of vision.
- 8 October 2019
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 18 (3) , 46-52
Open AccessThe modern view of congenital Сytomegalovirus infection
Congenital cytomegalovirus infection (CMVI) ranks first among congenital infections, making contribution significantly to the variety of congenital defects formation. The review describes in details the pathogenic mechanisms of the virus effects on the fetus and newborn. Congenital CMVI develops as a result of infection of the mother with the virus or its reactivation, causing an active infection. CMV is pantropic. Infected cells acquire the characteristic appearance of an «owl’s eye» due to a 3—4-fold increase in size, and the cytoplasm is visualized only in the form of a thin strip due to the large diameter of the nucleus. With a congenital CMV infection, the virus itself, its DNA or antigens is detected in biological media up to 14—21 days of life. The manifest and asymptomatic form of infection is distinguished.Attention is drawn to the various clinical findings and long-term outcomes of the infection. When the fetus is infected in the early stages of pregnancy, various malformations of the central nervous system, cardiovascular, kidneys, etc. are formed. When infected in the late stages of pregnancy, a variety of diseases and pathological conditions are revealed in newborns. In 40—90% of newborns with manifest CMVI, there are long-term neurological consequences and hearing loss, as well as damage to the organ of vision.